3M launches Nexcare with Microvex cold sore remedy

DESTIN, Fla. 3M in March debuted a new cold sore treatment, called Nexcare with Microvex Cold Sore Treatment, at the ECRM Cough/Cold and Allergy conference in Destin, Fla. The new cold sore remedy contains benzocaine for pain relief and allantoin as a skin protectant, as well as vitamins E and C and tee tree oil.

The bevy of ingredients is designed to provide fast pain relief, soften scabs and protect and relieve chapped lips, all with a non-greasy formula.

According to 3M research, cold sore remedies are not seasonal—the approximated 60 million sufferers buy all year long. Winter is the heaviest season, with 33 percent of sufferers seeking relief, followed by 23 percent who seek relief in the fall and summer and 21 percent who seek relief in the spring.

“We’re very excited to supplement our successful skin care line by launching into a new category where Nexcare products can make a difference in the lives of cold sore sufferers,” stated General Manager of 3M’s Consumer Health Care Department, Paul Hansen. “3M enjoys a strong legacy of advances in the healthcare space, with 60 years of product development for professional clinicians, and a nearly 30-year history of innovations focused on skin wellness.”